CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patientโs EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patientโs EEG data.
์ข
๋ชฉ ์ฝ๋ CBLL
ํ์ฌ ์ด๋ฆCeribell Inc
์์ฅ์ผOct 11, 2024
CEOChao (Xingjuan)
์ง์ ์281
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃOct 11
์ฃผ์360 N. Pastoria Avenue
๋์SUNNYVALE
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ94085
์ ํ18004360826
์น์ฌ์ดํธhttps://ceribell.com/
์ข
๋ชฉ ์ฝ๋ CBLL
์์ฅ์ผOct 11, 2024
CEOChao (Xingjuan)